Fullerene (C60) nanoparticles exert photocytotoxicity through modulation of reactive oxygen species and p38 mitogen-activated protein kinase activation in the MCF-7 cancer cell line

被引:0
|
作者
Zhi Li
Fei-long Zhang
Zhiyuan Wang
Li-li Pan
Ying-ying Shen
Zhen-zhong Zhang
机构
[1] Zhengzhou University,School of Pharmaceutical Sciences
来源
关键词
Fullerene (C60); Photocytotoxicity; Cell cycle; p38MAPK; ROS; Health and safety effects;
D O I
暂无
中图分类号
学科分类号
摘要
The photocytotoxicity of water-dispersed 100–300 nm fullerene amino acid derivatives nanoparticles was studied. The nanoparticle solution of fullerene derivatives, l-phenylalanine (C60-phe) and glycine (C60-gly), suppressed the in vitro growth of MCF-7 cells lines, induced cancer cells apoptosis, and caused a perturbation of the cell cycle. These nanoparticle solutions increased intracellular reactive oxygen species after irradiation. C60-phe or C60-gly upregulated the expression of phosphorylated (p)p38 mitogen-activated protein kinase (MAPK). N-Acetyl-l-cysteine significantly depressed the composite-induced activation of p38MAPK, and the kinase inhibitor SB203580 significantly prevented C60 derivative-induced cell apoptosis. This study revealed that p38MAPK is activated by C60 nanoparticles through triggering reactive oxygen species generation, leading to cancer cell injuries.
引用
收藏
相关论文
共 50 条
  • [1] Fullerene (C60) nanoparticles exert photocytotoxicity through modulation of reactive oxygen species and p38 mitogen-activated protein kinase activation in the MCF-7 cancer cell line
    Li, Zhi
    Zhang, Fei-long
    Wang, Zhiyuan
    Pan, Li-li
    Shen, Ying-ying
    Zhang, Zhen-zhong
    [J]. JOURNAL OF NANOPARTICLE RESEARCH, 2013, 15 (12)
  • [2] Tumorigenicity of MCF-7 human breast cancer cells lacking the p38α mitogen-activated protein kinase
    Mendoza, Rhone A.
    Moody, Emily E.
    Enriquez, Marlene I.
    Mejia, Sylvia M.
    Thordarson, Gudmundur
    [J]. JOURNAL OF ENDOCRINOLOGY, 2011, 208 (01) : 11 - 19
  • [3] Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling
    Emerling, BM
    Platanias, LC
    Black, E
    Nebreda, AR
    Davis, RJ
    Chandel, NS
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (12) : 4853 - 4862
  • [4] Modulation of vascular smooth muscle cell alignment by cyclic strain is dependent on reactive oxygen species and P38 mitogen-activated protein kinase
    Chen, QH
    Li, W
    Quan, ZW
    Sumpio, BE
    [J]. JOURNAL OF VASCULAR SURGERY, 2003, 37 (03) : 660 - 668
  • [5] Regulation of p38 mitogen-activated protein kinase during NK cell activation
    Chini, CCS
    Boos, MD
    Dick, CJ
    Schoon, RA
    Leibson, PJ
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (10) : 2791 - 2798
  • [6] Tenascin-X Induces Cell Detachment through p38 Mitogen-Activated Protein Kinase Activation
    Fujie, Shinpei
    Maita, Hiroshi
    Ariga, Hiroyoshi
    Matsumoto, Ken-ichi
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2009, 32 (10) : 1795 - 1799
  • [7] Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species
    Lu, Jin-Jian
    Meng, Ling-Hua
    Cai, Yu-Jun
    Chen, Qin
    Tong, Lin-Jiang
    Lin, Li-Ping
    Ding, Jian
    [J]. CANCER BIOLOGY & THERAPY, 2008, 7 (07) : 1017 - 1023
  • [8] p38 Mitogen-Activated Protein Kinase in beryllium-induced dendritic cell activation
    Li, L.
    Huang, Z.
    Gillespie, M.
    Mroz, P. M.
    Maier, L. A.
    [J]. HUMAN IMMUNOLOGY, 2014, 75 (12) : 1155 - 1162
  • [9] Differential expression and activation of p38 mitogen-activated protein kinase α, β, γ, and δ in inflammatory cell lineages
    Hale, KK
    Trollinger, D
    Rihanek, M
    Manthey, CL
    [J]. JOURNAL OF IMMUNOLOGY, 1999, 162 (07): : 4246 - 4252
  • [10] The contribution of reactive oxygen species and p38 mitogen-activated protein kinase to myofilament oxidation and progression of heart failure in rabbits
    Heusch, P.
    Canton, M.
    Aker, S.
    van de Sand, A.
    Konietzka, I.
    Rassaf, T.
    Menazza, S.
    Brodde, O. E.
    Di Lisa, F.
    Heusch, G.
    Schulz, R.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2010, 160 (06) : 1408 - 1416